A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 14507756.
- Also identified by PMC identifier 1920780.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To compare 2% econazole and 5% natamycin in the management of fungal keratitis. A randomised clinical trial was performed using 2% econazole or 5% natamycin as the two treatment arms on patients presenting with culture positive fungal keratitis to the cornea service at Aravind Eye Care System, Madurai, India. 116 patients were recruited, and 112 continued in the study. There were no significant differences between the two arms at baseline or for success (defined as a healed or healing ulcer) at final visit (p = 0.79). 2% Econazole appears to be as effective as 5% natamycin for the management of fungal keratitis.
Medical subject headings
- Antifungal Agents
- Econazole
- Eye Infections, Fungal
- Keratitis
- Natamycin